Dermot Kelleher | |
---|---|
Website | http://www.med.ubc.ca/person/dermot-kelleher/ |
Scientific career | |
Institutions | |
Thesis | T-cell immunoregulation in Crohn's disease (1995) |
Dermot P. Kelleher FMedSci is the Dean of the Faculty of Medicine and Vice-President, Health at the University of British Columbia in Vancouver, Canada.[1]
He moved to UBC in August 2015. He was subsequently appointed as UBC's inaugural Vice-President, Health in June 2018. Previously Kelleher was Dean of the Faculty of Medicine at Imperial College London. He took up this role on 1 October 2012.[2] From 2006 until 2012 he was Head of the School of Medicine and Vice-Provost for Medical Affairs at Trinity College, Dublin.[3] He was one of the three founders of Opsona Therapeutics in 2004; Opsona's research is primarily focused on the role of toll-like receptors (TLRs) and TLR signalling in human innate immunity.